Plasma tau levels in Alzheimer's disease

Plasma tau levels in Alzheimer's disease

Bibliographic Details
Main Authors:	Zetterberg, Henrik, Wilson, David, Andreasson, Ulf, Minthon, Lennart, Blennow, Kaj, Randall, Jeffrey, Hansson, Oskar
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707015/

Similar Items

Plasma tau in Alzheimer disease
by: Mattsson, Niklas, et al.
Published: (2016)

Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: A prospective 9-year study
by: Stomrud, Erik, et al.
Published: (2015)

Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer’s Disease
by: Hölttä, Mikko, et al.
Published: (2013)

Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease
by: Palmqvist, Sebastian, et al.
Published: (2015)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
by: Mattsson, Niklas, et al.
Published: (2016)

Comparison of Brief Cognitive Tests and CSF Biomarkers in Predicting Alzheimer’s Disease in Mild Cognitive Impairment: Six-Year Follow-Up Study
by: Palmqvist, Sebastian, et al.
Published: (2012)

Cerebrospinal Fluid Levels of sAPPα and sAPPβ in Lewy Body and Alzheimer's Disease: Clinical and Neurochemical Correlates
by: Mulugeta, Ezra, et al.
Published: (2011)

Fluid biomarkers in Alzheimer’s disease – current concepts
by: Rosén, Christoffer, et al.
Published: (2013)

Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
by: Voevodskaya, Olga, et al.
Published: (2016)

No Diagnostic Value of Plasma Clusterin in Alzheimer's Disease
by: Silajdžić, Edina, et al.
Published: (2012)

Tau Pathology and Parietal White Matter Lesions Have Independent but Synergistic Effects on Early Development of Alzheimer's Disease
by: Hertze, Joakim, et al.
Published: (2013)

Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson’s disease with dementia and dementia with Lewy bodies compared to Alzheimer’s disease
by: Hansson, Oskar, et al.
Published: (2014)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
by: Kvartsberg, Hlin, et al.
Published: (2015)

Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer’s disease: an observational study
by: Hertze, Joakim, et al.
Published: (2014)

Plasma β-amyloid in Alzheimer’s disease and vascular disease
by: Janelidze, Shorena, et al.
Published: (2016)

Evaluation of a Previously Suggested Plasma Biomarker Panel to Identify Alzheimer's Disease
by: Björkqvist, Maria, et al.
Published: (2012)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
by: Andreasson, Ulf, et al.
Published: (2016)

Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease
by: Öhrfelt, Annika, et al.
Published: (2016)

No diurnal variation of classical and candidate biomarkers of Alzheimer’s disease in CSF
by: Cicognola, Claudia, et al.
Published: (2016)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
by: Janelidze, Shorena, et al.
Published: (2015)

A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer’s Disease
by: Andersson, Carl-Henrik, et al.
Published: (2016)

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular events
by: Blennow, Kaj, et al.
Published: (2015)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
by: Rosén, Christoffer, et al.
Published: (2014)

SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer’s disease
by: Brinkmalm, Ann, et al.
Published: (2014)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
by: Piotr Lewczuk, et al.
Published: (2018-07-01)

Discriminatory Analysis of Biochip-Derived Protein Patterns in CSF and Plasma in Neurodegenerative Diseases
by: Rosén, Christoffer, et al.
Published: (2011)

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease
by: Janelidze, Shorena, et al.
Published: (2016)

Cerebrospinal Fluid (CSF) 25-Hydroxyvitamin D Concentration and CSF Acetylcholinesterase Activity Are Reduced in Patients with Alzheimer's Disease
by: Johansson, Per, et al.
Published: (2013)

Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.
by: Per Johansson, et al.

Cerebral white matter lesions – associations with Aβ isoforms and amyloid PET
by: van Westen, Danielle, et al.
Published: (2016)

Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis
by: Mattsson, Niklas, et al.
Published: (2016)

Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
by: Meredith Jr., Jere E., et al.
Published: (2013)

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease
by: Öhrfelt, Annika, et al.
Published: (2011)

Levels of ADAM10 are reduced in Alzheimer’s disease CSF
by: Aitana Sogorb-Esteve, et al.
Published: (2018-07-01)

Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease
by: Hall, Sara, et al.
Published: (2016)

Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samples
by: Skillbäck, Tobias, et al.
Published: (2013)

Biomarkers for Microglial Activation in Alzheimer's Disease
by: Lautner, Ronald, et al.
Published: (2011)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
by: Ann De Vos, et al.
Published: (2017-08-01)

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
by: Degerman Gunnarsson, Malin, et al.
Published: (2016)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
by: Hellwig, Konstantin, et al.
Published: (2015)